Sleptay

Series-A
synphatec.com Biotech & Healthcare Shanghai, China
Total Funding Undisclosed
Latest Round Undisclosed Series-A
Last Announced Sep 28, 2026
Investors 6 Backers
Decision Makers Profile Active

About Sleptay

Sleptay is an innovative biopharmaceutical company, developing next-generation therapies for central nervous system diseases.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Shanghai, China
Tracked Since Oct 4, 2026

Web & Domain Identity

Official Website synphatec.com
Domain Registered Date Sep 27, 2022

Social & Network Presence

X / Twitter Profile @companies
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Series-A announced

    Backed by Decheng Capital, China Merchants Venture

  2. Milestone

    Website domain registered

    synphatec.com

Investors & Backers

6
China Merchants Venture
Decheng Capital
Huatai Zijin Investment
Morningside
Qianju Capital
Shunwei Capital

Funding History

1 Round
Series-A equity · Sep 28, 2026

Round backers: Decheng Capital, China Merchants Venture, Huatai Zijin Investment, Morningside, Qianju Capital, Shunwei Capital

Undisclosed

Founders & Leadership

2

Yang Geng

Co-Founder & CEO

Work email & phone locked Unlock →

Yelin Chen

Founder & Chairman

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts